Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT05328596
Starting soon Not applicable

CBT Treatment for Internet Gaming Disorder

NCT05328596 · tracked via the Priya Life Science Sweden tracker
Sponsor
Sahlgrenska University Hospital
Phase
Not applicable
Started
2025-08
Last updated
2025-05-16

Condition(s) studied

Internet Gaming DisorderGaming Disorder

Investigational drug(s) / intervention(s)

CBT-treatmentWait list control

CBT-treatment: Cognitive Behavioral Treatment for Gaming Disorder.

Wait list control: No intervention

Study summary

For most people, gaming is perceived as a positive activity. In some cases, however, gaming may turn into an addiction with consequences for the individual health, quality of life and everyday life. Today, there is a lack of evidence-based interventions to treat this condition, called Gaming Disorder (GD). This study will evaluate a new manual for treatment of GD, divided into a number of modules and based on cognitive behavioural therapy (CBT). The study is designed as a randomized controlled trial (RCT) and will be conducted at a clinic specialized in the treatment of gambling and gaming addiction.

Participants included in the study will be randomized to one of to groups. The intervention group will receive twelve weeks of individual CBT-treatment while participants allocated to the control group will be put on a twelve-week wait-list.

The hypothesis is that the manual based CBT treatment will result in a greater reduction in symptoms of criteria for GD.

Eligibility

Sex
ALL
Min age
16 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Fulfilling 5 out of 9 criteria for IGD according to DSM V * ≥ 16 years of age * Can read and speak Swedish fluidly. Exclusion Criteria: * Somatic or psychiatric disease that is contraindicating or severely complicates the implementation of the intervention (e.g., ongoing psychotic, manic or hypomanic episode or neuropsychiatric condition with severe disability) * Ongoing increased suicide risk that is considered to make it inappropriate for the patient to participate in the study (based on evaluation at the structured clinical interview) * have another ongoing psychological treatment with a content similar to that in the current study * plan to start such treatment during the XX weeks that the study is ongoing or has during the last three weeks started or changed medication for any psychiatric problem.

Primary outcome measure(s)

  • Internet Gaming Disorder Scale- Short Form (IGDS9-SF) — Up to 24 weeks.
    Change in number of diagnostic criteria of Internet Gaming Disorder according to DSM-5. The score ranges from 9 to 45. A higher score indicates more problems related to gaming.

Trial sites (1)

FacilityCityRegionStatus
Clinic for gambling addiction and screen health Gothenburg Sweden

More Sahlgrenska University Hospital trials in Sweden

Venous Resection in Patients Undergoing Pancreatic Surgery Starting soon
Preventive Physical Activity Intervention in Head and Neck Cancer Recruiting
VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients Recruiting
Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia Recruiting
Reperfusion Treatment in Acute Pulmonary Embolism Recruiting

Other trials for the same condition

Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05328596 on ClinicalTrials.gov ↗ ← All trials in Sweden